Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Zscaler Positioned as Leader in New Tier 1 Analyst Firm Security Service Edge Research Report
-
ManTech Wins $166 Million Defense Health Agency Contract
-
Verizon Business unveils AI-Powered ‘Experiences Room’ at Enterprise Connect
-
ContextLogic Stockholders Can Vote Today “FOR” the Value Maximizing Transaction with Qoo10
-
Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic
-
Algoma Steel Provides Fiscal Fourth Quarter 2024 Guidance
-
PrismaStake: Navigating Crypto Volatility with Innovative Staking Platform
-
Algoma Steel Inc. Announces Proposed Offering of US$350 Million of Senior Secured Second Lien Notes due 2029
-
Olink publishes 2023 annual report
-
Olink reports fourth quarter and full year 2023 financial results
-
MISTRAS Group Appoints New Chief Transformation Officer to Advance Business Transformation
-
ISANDISOFX.COM Lights Up Nasdaq Screen in Times Square, New York
-
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
-
Bluejay Announces Receipt of PRIME Designation from European Medicines Agency (EMA) for BJT-778 for the Treatment of Chronic Hepatitis Delta Virus Infection
-
Luxshare-TECH Preview for OFC 2024: Optical Interconnect Products Inject New Vitality into the AI Industry
-
One World Products, Inc. Secures Exclusive Rights With Procepack for State-of-the-Art PreRoll-Er Equipment in Colombia
-
Luxshare-TECH Preview for OFC 2024: Collaborating with Ecosystem Partners to Explore Cutting-Edge Technologies
-
Turtle Creek Asset Management Releases Open Letter to Gildan Board Calling on it to Hold the Annual Meeting Without Delay
-
Starton Therapeutics to Present at Upcoming MedInvest and Needham Conferences
-
Woodward Announces Exclusive Thrust Reverser Actuation (TRAS) Systems Repair Agreement with Alliance Airlines
-
NewAmsterdam Pharma to Present New Analysis from the Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe at 2024 American College of Cardiology Congress
-
Unveiling the Future of Global CX; MCI Acquires Market Force Information, a Customer Experience Services Powerhouse
-
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
-
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
-
Equipment Leasing and Finance Association’s Survey of Economic Activity: Monthly Leasing and Finance Index
-
Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
-
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
-
Liberty Military Housing Earns Tenth Consecutive Resident Satisfaction Honors
-
Notice to convene the annual general meeting in FirstFarms A/S
-
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
-
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
-
Novo Nordisk A/S - share repurchase programme
-
Ideanomics Announces Fourth-Quarter and Full-Year 2023 Earnings Call Details
-
Dominica reaches monumental agreement with other Caribbean Citizenship by Investment nations
-
MetasTx LLC Celebrates Dr. David Crich’s Achievement of the 2024 James Flack Norris Award in Physical Organic Chemistry
-
Crown Castle Issues Open Letter to Shareholders
-
AMC Networks Commences Tender Offer for Any and All Senior Notes due 2025
-
AMC Networks Inc. Announces Proposed Private Offering of $700 Million of Senior Secured Notes due 2029
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
St Kitts and Nevis leads the regional agreement on Citizenship by Investment regulations
-
Aecon schedules first quarter 2024 financial results release and conference call
-
Captivision Announces New Global Leadership
-
Theriva™ Biologics Reports Full-Year 2023 Operational Highlights and Financial Results
-
Aqua-Tots Swim School Invites Sterling Community To Celebrate Grand Opening With Swim-sational Extravaganza
-
Blackwells Capital: Nelson Peltz is Not the Change Disney’s Board Needs
-
Hallador Energy Company Announces the Appointment of Marjorie Hargrave as Chief Financial Officer
-
TILT Holdings Crowned a NECANN Cup Winner Third Year in a Row
-
Dyne Therapeutics Announces CEO Transition
-
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
-
Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
